Rigel Pharmaceuticals reported $1.64M in Stock for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Alexion Pharmaceuticals ALXN:US $ 803.9M 28.2M
Amgen AMGN:US $ 4152M 37M
Biomarin Pharmaceutical BMRN:US $ 749.41M 38.43M
Bristol Myers Squibb BMY:US $ 2163M 26M
Daiichi Sankyo 4568:JP Y 209990M 1818M
Eli Lilly And LLY:US $ 3907.4M 82.5M
Flexion Therapeutics FLXN:US $ 14.67M 2.37M
Halozyme Therapeutics HALO:US $ 55.98M 2.58M
Heron Therapeutics HRTX:US $ 41.5M 1.3M
Intrexon XON:US $ 9.94M 1.48M
IONIS PHARMACEUT IONS:US $ 22.93M 1.17M
Karyopharm Therapeutics KPTI:US $ 3.94M 38K
Ligand Pharmaceuticals LGND:US $ 33M 6.95M
Neurocrine Biosciences NBIX:US $ 25.5M 2.8M
Regeneron Pharmaceuticals REGN:US $ 1550.1M 433.8M
Ultragenyx Pharmaceutical RARE:US $ 15.19M 0.11M
Veracyte VCYT:US $ 9.82M 3.15M